Literature DB >> 8093642

A 1.5-megabase yeast artificial chromosome contig from human chromosome 10q11.2 connecting three genetic loci (RET, D10S94, and D10S102) closely linked to the MEN2A locus.

T C Lairmore1, S Dou, J R Howe, D Chi, K Carlson, R Veile, S K Mishra, S A Wells, H Donis-Keller.   

Abstract

The genetic loci RET, D10S94, and D10S102 from human chromosome 10q11.2 are very closely linked to a locus responsible for the multiple endocrine neoplasia type 2 (MEN2A and MEN2B) and medullary thyroid carcinoma (MTC1) familial cancer syndromes. We have constructed a 1.5-megabase contig consisting of six genomic yeast artificial chromosome clones which include these loci and define their physical order. A critical crossover event has been identified within the map interval; this event places the MEN2A locus centromeric to D10S102 and defines the orientation of the physical map on the chromosome. The orientation of the contig and order of the markers are centromere-RET-D10S94-D10S102-telomere. In addition, a microsatellite repeat polymorphism with a heterozygosity of 71% at the RET locus and a restriction fragment length polymorphism with a heterozygosity of 42% detected by a lambda clone from the D10S94 locus have been developed for high-resolution genetic linkage mapping and predictive diagnostic testing. These data place three important markers on a contiguous physical map, narrow the MEN2 disease locus interval, and provide a framework for further candidate gene identification efforts. Placement of these genetic loci along a clone-based map and continued expansion of the contig will also facilitate efforts to determine the relationship of physical to genetic distance near the centromeres of human chromosomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093642      PMCID: PMC45689          DOI: 10.1073/pnas.90.2.492

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  In vivo footprinting of a muscle specific enhancer by ligation mediated PCR.

Authors:  P R Mueller; B Wold
Journal:  Science       Date:  1989-11-10       Impact factor: 47.728

2.  ret transforming gene encodes a fusion protein homologous to tyrosine kinases.

Authors:  M Takahashi; G M Cooper
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

3.  Activation of a novel human transforming gene, ret, by DNA rearrangement.

Authors:  M Takahashi; J Ritz; G M Cooper
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

4.  Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma.

Authors:  S A Narod; H Sobol; Y Nakamura; C Calmettes; J L Baulieu; J C Bigorgne; G Chabrier; J Couette; J L de Gennes; J Duprey
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

5.  Linked markers flanking the gene for multiple endocrine neoplasia type 2A.

Authors:  Y Nakamura; C G Mathew; H Sobol; D F Easton; H Telenius; T Bragg; K Chin; J Clark; C Jones; G M Lenoir
Journal:  Genomics       Date:  1989-08       Impact factor: 5.736

6.  The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.

Authors:  M Santoro; R Rosati; M Grieco; M T Berlingieri; G L D'Amato; V de Franciscis; A Fusco
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

7.  Isolation of single-copy human genes from a library of yeast artificial chromosome clones.

Authors:  B H Brownstein; G A Silverman; R D Little; D T Burke; S J Korsmeyer; D Schlessinger; M V Olson
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

8.  Identification and characterization of a gene at D10S94 in the MEN2A region.

Authors:  H McDonald; D Smailus; H Jenkins; K Adams; N E Simpson; P J Goodfellow
Journal:  Genomics       Date:  1992-06       Impact factor: 5.736

9.  Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.

Authors:  N E Simpson; K K Kidd; P J Goodfellow; H McDermid; S Myers; J R Kidd; C E Jackson; A M Duncan; L A Farrer; K Brasch
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

10.  A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.

Authors:  C G Mathew; K S Chin; D F Easton; K Thorpe; C Carter; G I Liou; S L Fong; C D Bridges; H Haak; A C Kruseman
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

View more
  13 in total

Review 1.  Translational research in endocrine surgery.

Authors:  Scott K Sherman; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2013-07-26       Impact factor: 3.495

2.  Construction of radiation-reduced hybrids and their use in mapping of microclones from chromosome 10p11.2-q11.2.

Authors:  S Fujita; E Shin; T Nakamura; H Kurahashi; Y Kaneda; K Tanaka; T Mori; S Takai; I Nishisho
Journal:  Jpn J Hum Genet       Date:  1993-12

3.  The organisation of repetitive sequences in the pericentromeric region of human chromosome 10.

Authors:  M S Jackson; P Slijepcevic; B A Ponder
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

4.  A multiple interval physical map of the pericentromeric region of human chromosome 10.

Authors:  A Tunnacliffe; M S Jackson; E Gardner; D R Love; J K Moore; S E Mole; L M Mulligan; A Graham; G Finocchiaro; S Orstavik
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

5.  Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine.

Authors:  I Schuffenecker; N Ginet; D Goldgar; C Eng; B Chambe; A Boneu; C Houdent; D Pallo; M Schlumberger; C Thivolet; G M Lenoir
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

6.  Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus.

Authors:  P Edery; A Pelet; L M Mulligan; L Abel; T Attié; E Dow; D Bonneau; A David; W Flintoff; D Jan
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

7.  Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.

Authors:  S A Wells; D D Chi; K Toshima; L P Dehner; C M Coffin; S B Dowton; J L Ivanovich; M K DeBenedetti; W G Dilley; J F Moley
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

Review 8.  Medical management of metastatic medullary thyroid cancer.

Authors:  Jessica E Maxwell; Scott K Sherman; Thomas M O'Dorisio; James R Howe
Journal:  Cancer       Date:  2014-06-18       Impact factor: 6.860

9.  Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.

Authors:  A Frilling; W Höppner; C Eng; L Mulligan; F Raue; C E Broelsch
Journal:  J Mol Med (Berl)       Date:  1995-05       Impact factor: 4.599

10.  Chemical genetic discovery of targets and anti-targets for cancer polypharmacology.

Authors:  Arvin C Dar; Tirtha K Das; Kevan M Shokat; Ross L Cagan
Journal:  Nature       Date:  2012-06-06       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.